See more : K&S Corporation Limited (KSC.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Cannabis Suisse Corp. (CSUI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannabis Suisse Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Blue Dolphin Energy Company (BDCO) Income Statement Analysis – Financial Results
- Reliance Home Finance Limited (RELHOME.BO) Income Statement Analysis – Financial Results
- Silk Logistics Holdings Limited (SLH.AX) Income Statement Analysis – Financial Results
- China Creative Global Holdings Limited (1678.HK) Income Statement Analysis – Financial Results
- F.N.B. Corporation (FNB) Income Statement Analysis – Financial Results
Cannabis Suisse Corp. (CSUI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannabissuissecorp.com
About Cannabis Suisse Corp.
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. It provides health-related supplements, and face masks and disinfectants, as well as retails cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.00K | 10.00K | 7.77K | 50.85K | 242.74K | 7.53K | 6.50K | 14.19K | 0.00 |
| Cost of Revenue | 30.07K | 9.17K | 1.73K | 102.65K | 327.53K | 2.54K | 2.30K | 3.90K | 0.00 |
| Gross Profit | -67.00 | 834.00 | 6.04K | -51.80K | -84.79K | 4.99K | 4.20K | 10.29K | 0.00 |
| Gross Profit Ratio | -0.22% | 8.34% | 77.68% | -101.86% | -34.93% | 66.29% | 64.57% | 72.53% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 252.63K | 339.27K | 161.19K | 297.01K | 246.46K | 22.22K | 13.72K | 22.41K | 1.60K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.97K | 0.00 |
| SG&A | 252.63K | 339.27K | 161.19K | 297.01K | 246.46K | 22.22K | 13.72K | 34.38K | 1.60K |
| Other Expenses | 4.24K | 0.00 | 2.00K | 9.65K | 20.07K | 5.50K | 6.90K | 2.59K | 0.00 |
| Operating Expenses | 256.87K | 343.52K | 163.19K | 306.66K | 266.53K | 27.72K | 20.62K | 36.97K | 1.73K |
| Cost & Expenses | 286.94K | 352.68K | 164.93K | 409.30K | 594.06K | 30.26K | 22.92K | 40.86K | 1.73K |
| Interest Income | 733.76K | 8.87K | 63.58K | 60.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.80K | 8.87K | 63.58K | 60.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -898.63K | 4.24K | 2.00K | 9.65K | 20.07K | 5.50K | 6.90K | 2.59K | 1.73K |
| EBITDA | -1.16M | -338.44K | -122.31K | -340.90K | -369.16K | -17.23K | -16.42K | -26.67K | -1.73K |
| EBITDA Ratio | -3,851.89% | -3,384.38% | -1,996.86% | -660.83% | -136.46% | -228.75% | -146.55% | -169.70% | 0.00% |
| Operating Income | -256.94K | -342.68K | -157.16K | -358.45K | -351.32K | -22.73K | -16.42K | -26.67K | -1.73K |
| Operating Income Ratio | -856.46% | -3,426.82% | -2,022.59% | -704.92% | -144.73% | -301.83% | -252.63% | -187.94% | 0.00% |
| Total Other Income/Expenses | -1.01M | -8.87K | -30.74K | -52.44K | -37.91K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.26M | -351.55K | -187.89K | -410.89K | -389.23K | -22.73K | -16.42K | -26.67K | -1.73K |
| Income Before Tax Ratio | -4,215.43% | -3,515.47% | -2,418.15% | -808.05% | -160.35% | -301.83% | -252.63% | -187.94% | 0.00% |
| Income Tax Expense | 0.00 | -163.65K | 30.74K | 60.34K | -186.23K | -2.54K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.26M | -351.55K | -218.63K | -471.24K | -389.23K | -22.73K | -16.42K | -26.67K | -1.73K |
| Net Income Ratio | -4,215.43% | -3,515.47% | -2,813.71% | -926.72% | -160.35% | -301.83% | -252.63% | -187.94% | 0.00% |
| EPS | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 47.32M | 42.04M | 33.07M | 34.50M | 35.54M | 51.98M | 57.10M | 57.10M | 57.10M |
| Weighted Avg Shares Out (Dil) | 47.32M | 42.04M | 33.07M | 34.50M | 35.54M | 51.98M | 57.10M | 57.10M | 57.10M |
Source: https://incomestatements.info
Category: Stock Reports